The effects of quercetin on bone minerals, biomechanical behavior, and structure in streptozotocin-induced diabetic rats

Cell Biochemistry and Function

Volumn 25, Issue 6, 2007, Pages 747-752

  Kanter, Mehmet ^a   Altan, Mehmet Fatih ^b   Donmez, Senayi ^c   Ocakci, Ayse ^b   Kartal, Murat Emre ^b  

^a TRAKYA UNIVERSITY   (Turkey)

^b ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

^c ANKARA UNIVERSITY   (Turkey)

Author keywords

Biomechanical behaviour; Bone mass; Diabetes mellitus; Quercetin; Streptozotocin

Indexed keywords

CALCIUM; INSULIN; MAGNESIUM; QUERCETIN; ANTIOXIDANT; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BLOOD SAMPLING; BONE MINERAL; BONE STRUCTURE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DIAPHYSIS; DRUG EFFECT; FEMUR; FEMUR NECK; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; MAGNESIUM BLOOD LEVEL; MALE; MINERAL METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; BONE DENSITY; CHEMICALLY INDUCED DISORDER; CLASSIFICATION; EXPERIMENTAL DIABETES MELLITUS; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; PATHOPHYSIOLOGY; RANDOMIZATION; WISTAR RAT;

ANIMALIA; RATTUS;

ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; BIOMECHANICS; BLOOD GLUCOSE; BONE DENSITY; CALCIUM; DIABETES MELLITUS, EXPERIMENTAL; FEMUR NECK; INJECTIONS, INTRAPERITONEAL; INSULIN; MAGNESIUM; MALE; QUERCETIN; RANDOM ALLOCATION; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 38449102064     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1397     Document Type: Article

References (33)

1. Gunczler P, Lanes R, Paoli M, Martinez V, Villarel O, Weisinger JR. Decreased bone mineral density and bone formation markers shortly after diagnosis of clinical type 1 diabetes mellitus. J Pediatr Endocrinol Meta 2001; 14: 525-528.
2. Kanter M, Yoruk M, Koc A, Meral I, Karaca T. Effects of cadmium exposure on morphological aspects of pancreas, weights of fetus and placenta in streptozotocin-induced diabetic pregnant rats. Biol Trace Elem Res 2003; 93: 189-200.
3. Kanter M, Coskun O, Korkmaz A, Oter S. Effects of Nigella sativa on oxidative stress and beta cell damage in streptozotocin-induced diabetic rats. The Anat Rec Part A 2004; 279: 685-691.
4. Middleton E, Jr. Effect of plant flavonoids on immune and inflammatory cell function, Adv Exp Med Biol 1998; 439: 175-182 Review.
5. Inal ME, Akgun A, Kahramanet A. Radioprotective effects of exogenous glutathione against whole-body gamma-ray irradiation: age- and gender-related changes in malondialdehyde levels, superoxide dismutase and catalase activities in rat liver. Methods Find Exp Clin Pharmacol 2002; 24: 209-212.
6. Coskun O, Kanter M, Armutcu F, Cetin K, Kaybolmaz B, Yazgan O. Protective effects of quercetin, a flavonoid antioxidant, in absolute ethanol-induced acut gastric ulcer. Eur J Gen Med 2004; 1: 37-42.
7. Bors W, Heller W, Michel C, Saran M. Flavonoids as antioxidants: determination of radical-scavenging efficiencies. Methods Enzymol 1990; 186: 343-355.
8. Coskun O, Kanter M, Korkmaz A, Oter S. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and β-cell damage in rat pancreas. Pharm Res 2005; 51: 117-123.
9. Afanas'ev IB, Dorozhko I, Brodskii AV, Korstyuk VA, Potapovitch A. Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxid ation. Biochem Pharmacol 1989; 38: 1763-1769.
10. Prouillet C, Maziere JC, Maziere C, Wattel A, Brazier M, Kamel S. Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway. Biochem Pharmacol 2004; 67: 1307-1313.
11. Wattel A, Kamel S, Mentaverri R, et al. Potent inhibitory effect of naturally occurring flavonoids quercetin and kaempferol on in vitro osteoclastic bone resorption. Biochem Pharmacol 2003; 65: 35-42.
12. Riggs BL, Warmer HW, Seeman E, et al. Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndrome. J Clin Invest 1982; 70: 716-723.
13. Reid IR. Therapy of osteoporosis: calcium, vitamin D. and exercise. Am J Med Sci 1996; 312: 278-286.
14. Morley P, Whitfield JF, Willick GE. Anabolic effects of PTH on bone. Trends Endocrinol Metab 1997; 8: 225-231.
15. Kurland ES, Cosman F, McMahon DJ, Rosen CJ, Lindsay R, Bilezikian JP. Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers. J Clin Endocrinol Metab 2000; 85: 3069-3076.
16. Coskun O, Ocakci A, Bayraktaroglu T, Kanter M. Exercise training prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Tohoku J Exp Med 2004; 203: 145-154.
17. Vessal M, Hemmati M, Vasie M. Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp Biochem Physiol C Toxicol Pharmacol 2003; 135: 357-364.
18. Yenson M. Clinical Biochemistry. Beta Press: Istanbul, Turkey, 1986.
19. Wolf E, Röser K, Hahn M, Welkerling H, Delling G. Enzyme and imunohistochemistry on undecalcified bone and bone marrow biopsies after embedding in plastic: a new embedding method for routine application. Virchows Arch A Pathol Anat Histopathol 1992; 420: 17-24.
20. Schenk RK, Olah AJ, Herrmann W. Preparation of calcified tissues for light microscopy. In Methods of Calcified Tissues Preparation, Dickson GR (ed.). Elsevier: Amsterdam, 1984: 1-56.
21. Lesclous P, Guez D, Saffar JL. Short-term prevention of osteoclastic resorption and osteopenia in ovariectomized rats treated with the H-2 receptor antagonist cimetidine. Bone 2002; 30: 131-136.
22. Parfitt AM, Mathews CHE, Villanueva AR, Kleerekoper M, Frame B, Rao DS. Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest 1983; 72: 1396-1409.
23. Mosci P, Vecchiarelli A, Cenci E, Puliti M, Bistoni F. Low-dose treptozotocin-induced diabetes in mice. Cell Immunol 1993: 150: 27-35.
24. Kunjathoor V, Wilson D, LeBoeuf R. Increased atherosclerosis in streptozotocin-induced diabetic mice. J Clin Invest 1996; 97: 1767-1773.
25. Einhorn TA, Boskey AL, Gundberg CM, Vigorita VJ, Devlin VJ, Beyer MM. The mineral and mechanical properties of bone in chronic experimental diabetes. J Orthop Res 1988; 6: 317-323.
26. Goodman WG, Hori MT. Diminished bone formation in experimental diabetes, relationship to osteoid maturation and mineralization. Diabetes 1984; 33: 825-831.
27. Seino Y, Ishida H. Diabetic osteopenia: pathophysiology and clinical aspects. Diab Metab Rev 1995; 11: 21-35.
28. Verhaeghe J, Suiker AM, Einhorn TA, et al. Brittle bones in spontaneously diabetic female rats cannot be predicted by bone mineral measurements: studies in diabetic and ovariectomized rats. J Bone Miner Res 1994; 9: 1657-1667.
29. Hou JC, Zernicke RF. Barnard RJ. Experimental diabetes, insulin treatment, and femoral neck morphology and biomechanics in rats. Clin Orthop March 1991; 264: 278-285.
30. Dixit PK, Ekstrom RA. Decreased breaking strength of diabetic rat bone and its improvement by insulin treatment. Calcif Tissue Int 1980; 32: 195-199.
31. Olmos JM, Pérez-Castrillón JL, Garcia MT, Garrido JC, Amado JA, Gonzalez-Maćýas J. Bone densitometry and biochemical bone remodeling markers in type I diabetes mellitus. Bone Miner 1994; 26: 1-8.
32. Woo JT, Nakagawa H, Notoya M, et al. Quercetin suppresses bone resorption by inhibiting the differentiation and activation of osteoclasts. Biol Pharm Bull 2004; 27: 504-509.
33. Horcajada-Molteni MN, Crespy V, Coxam V, Davicco MJ, Remesy C, Barlet JP. Rutin inhibits ovariectomy-induced osteopenia in rats. J Bone Miner Res 2000; 15: 2251-2258.